ClinConnect ClinConnect Logo
Search / Trial NCT05975593

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Aug 1, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Radiotherapy Chemotherapy Cervical Cancer Pancreatic Cancer Biospecimen

ClinConnect Summary

This clinical trial is looking at how radiation therapy affects the environment around tumors in patients with locally advanced cervical cancer and pancreatic cancer. The study will collect various samples, like biopsies and blood, as well as treatment-related information before, during, and after patients receive standard radiation treatment. The goal is to better understand how these factors work together and how they might impact treatment outcomes.

To participate in this study, you need to be at least 18 years old and have been diagnosed with locally advanced or metastatic cervical or pancreatic cancer, with plans to receive standard radiation therapy. You also should be in good enough health to manage the procedures involved. If you decide to join, you can expect to provide samples and information that will help researchers learn more about the effects of radiation on cancer. Importantly, this study is currently recruiting participants, so it’s a great time to consider joining if you meet the criteria.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Confirmation of intent to receive radiotherapy for one of the following diagnoses:
  • Cervical cancer
  • Pancreatic cancer
  • ECOG performance status ≤ 2
  • At least 18 years old
  • Able to understand and willing to sign an IRB-approved written informed consent document
  • Exclusion Criteria:
  • Any issue (medical, anatomic, other) that might preclude safe acquisition of biospecimens at the discretion of the treating physician

About Washington University School Of Medicine

Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.

Locations

Saint Louis, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Cliff Robinson, M.D.

Principal Investigator

Washington University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported